STERIS AST offers medical device product testing capabilities to support our global expansions 

November 10, 2020

STERIS Applied Sterilization Technologies (AST) continues to expand its capacity for routine sterilization of medical devices, including new X-ray facilities in a number of locations worldwide.

In addition, STERIS is adding new specialized Radiation Technology Centers in the UK and North America.

Our STERIS laboratory testing services are integral in supporting these new facilities by providing medical device manufacturers with a comprehensive suite of microbiological and analytical testing and validation services to support registration of medical devices.

These tests include:

  • Full-service testing to support ISO 11137 - Dose Setting and Audits (VDmax and Method 1)
  • Full-service testing to support ISO 11135 (EO residual, Biological Indicator, Bioburden and Sterility Testing)
  • LAL testing for product release
  • Bioburden and environmental monitoring of routine production
  • Packaging testing validation support (ISO 11607)
  • Product testing including LUER Testing (ISO 80369-7)
  • Design verification and technical services for products

The increased complexity of medical devices is supported by an evolving sterilization services offering, including technologies such as X-ray and vaporized hydrogen peroxide (VHP).

By combining our global network of technology-neutral sterilization facilities, laboratory testing capabilities, and the technical knowledge of our TechTeam® professionals, STERIS AST supports Customers through new product registrations and technology transfers.

2020.01.08-Radiation-Sterilization-Validation-200px

About STERIS

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life sciences products and services. For more information, visit www.steris.com.

 
Related Posts
Female warehouse worker
June 6, 2025

STERIS Applied Sterilization Technologies is pleased to announce that the U.S. Occupational Safety and Health Administration (OSHA) has accepted its Groveport, Ohio operations into the agency’s prestigious Voluntary Protection Programs (VPP) at the Star Level. 

Libertyville Lab
May 28, 2025

As part of our long-term commitment to supporting global medical device and pharmaceutical manufacturing, STERIS is pleased to announce the International Safe Transit Association (ISTA) accreditation of our Brooklyn Park, Minnesota, USA laboratory to include environmental conditioning and transportation/distribution simulation testing services.

Exterior View of STERIS Facility in Batu Kawan, Malaysia
May 1, 2025

As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce a new ethylene oxide (EO) processing facility in Batu Kawan industrial Park in Penang, Malaysia.

202310-LibertyvilleIL-Lab-5
March 28, 2025
As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS Applied Sterilization Technologies (AST) is pleased to announce the addition of Extractables and Leachables (E&L) testing, featuring advanced chemical analysis.